HeartSciences Inc.
HSCSNASDAQHealthcare● Active
$1.84
$-0.10(-5.15%)
Market Cap$3987740
P/E Ratio—
52W High$6.47
52W Low$1.63
HeartSciences Inc. (HSCS) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · HSCS · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-04 | 2024-04 | 2023-04 | 2022-04 | 2021-04 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00M | $0.02M | $0.01M | $0.01M | $0.03M |
| Cost of Revenue | $0.13M | $0.10M | $0.03M | $0.03M | $0.04M |
| Gross Profit | ($0.13M) | ($0.08M) | ($0.02M) | ($0.02M) | ($0.02M) |
| Gross Margin %(computed) | — | -444.16% | -476.91% | -139.73% | -72.93% |
| Operating Expenses | |||||
| R&D Expenses | $4.39M | $2.88M | $2.46M | $3.00M | $1.71M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $8.23M | $6.22M | $6.09M | $4.69M | $2.55M |
| Operating Income | ($8.35M) | ($6.31M) | ($6.11M) | ($4.71M) | ($2.57M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.50M | $0.35M | $0.24M | $0.37M | $0.13M |
| Income Before Tax | ($8.77M) | ($6.61M) | ($6.35M) | ($4.83M) | ($2.45M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($8.77M) | ($6.61M) | ($6.35M) | ($4.83M) | ($2.45M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-9.34 | $-18.74 | $-6173.88 | $-137.94 | $-77.89 |
| Wtd Avg Shares | 0.94M | 0.35M | 0.08M | 0.03M | 0.03M |
| EBITDA | ($8.14M) | ($6.16M) | ($6.08M) | ($4.43M) | ($2.29M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more HeartSciences Inc. data
About HeartSciences Inc. (HSCS) Income Statement
HeartSciences Inc. (HSCS) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, HSCS reported revenue of $0.00B, gross profit of ($0.00B) (gross margin -2884.71%), and net income of ($0.01B) — a net profit margin of -201499.52%.
Frequently asked questions
HSCS · 4 questionsHeartSciences Inc. (HSCS) reported revenue of $0.00B for 2025, down 76.6% year-over-year.
HSCS revenueHSCS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08